Equities

Guanze Medical Information Industry (Holding) Co Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert

Guanze Medical Information Industry (Holding) Co Ltd

Actions
  • Price (HKD)2.99
  • Today's Change1.04 / 53.33%
  • Shares traded9.47m
  • 1 Year change+730.56%
  • Beta--
Data delayed at least 15 minutes, as of Feb 16 2026 04:08 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Guanze Medical Information Industry (Holding) Co Ltd is an investment holding company primarily engaged in the provision of medical imaging film products and software, and medical imaging cloud services. The Company is engaged in the sales of medical imaging films procured from international brands and medical imaging films and software under its own Guanze Huiyi brand to hospitals and healthcare institutions. The types of medical imaging films distributed or provided by the Company primarily include medical dry laser films, thermal films and medical printing films. The Company's medical imaging cloud services mainly include digital medical image cloud storage platform, digital medical image platform, regional imaging diagrams platform, and picture archiving and communication system (PACS) system. The Company mainly conducts its businesses within domestic market.

  • Revenue in HKD (TTM)166.94m
  • Net income in HKD23.45m
  • Incorporated2020
  • Employees58.00
  • Location
    Guanze Medical Information Industry (Holding) Co LtdRoom 501-A, Block 10, Strategic EmergingJI'NAN ChinaCHN
  • Websitehttps://www.guanzegroup.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.